PURCHASE AND SALE AGREEMENTPurchase and Sale Agreement • May 8th, 2018 • Polarityte, Inc. • Biological products, (no disgnostic substances) • Utah
FIRST AMENDMENT TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 8th, 2018 • Polarityte, Inc. • Biological products, (no disgnostic substances) • Utah
THIS FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT (“Amendment”), is entered into and shall be effective as of April 9, 2018 (“Effective Date”), by and between IBEX GROUP, L.L.C., a Utah limited liability company (“IBEX LLC”), IBEX PRECLINICAL RESEARCH, INC., a Utah corporation (“IBEX Corp.”) (IBEX Corp. and IBEX LLC are collectively referred to as “Seller”), POLARITYTE, INC., a Delaware corporation (“Parent”), and UTAH CRO SERVICES, INC., a Nevada corporation (“Acquisition Co.”) (Seller, Parent, and Acquisition Co. are referred to collectively in this Amendment as the “Parties” and, individually, as a “Party”), with reference to the following:
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 8th, 2018 • Polarityte, Inc. • Biological products, (no disgnostic substances) • New York
In addition to the Excluded Assets provided for in Section 2.01 of this Agreement, the following list of assets identified by IBEX Corp. (which assets may be updated or changed between the Effective Date and the Closing) are deemed part of the Excluded Assets:
FIRST AMENDMENT TO PURCHASE AND SALE AGREEMENTPurchase and Sale Agreement • May 8th, 2018 • Polarityte, Inc. • Biological products, (no disgnostic substances) • Utah
THIS FIRST AMENDMENT TO PURCHASE AND SALE AGREEMENT (“Amendment”), is entered into and shall be effective as of April 9, 2018 (“Effective Date”), by and between IBEX GROUP, L.L.C., a Utah limited liability company (“Seller”), and POLARITYTE, INC., a Delaware corporation (“Purchaser”) (Seller and Purchaser are referred to individually as a “Party” and collectively as the “Parties”), with reference to the following:
